Paper
0
Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial
Authors
Magdy Selim,Lydia Foster
Claudia Moy,Guohua Xi,Michael Hill,Lewis Morgenstern,Steven Greenberg,Michael James,Vineeta Singh,Wayne Clark,Casey Norton,Yuko Palesch,Sharon Yeatts,Monica Dolan,Erlinda Yeh,Kevin Sheth,Kimberly Kunze,Susanne Muehlschlegel,Iryna Nieto,Jan Claassen,Cristina Falo,David Huang,Anne Beckwith,Steven Messé,Melissa Yates,Kristine O’Phelan,Andrea Escobar,Kyra Becker,Patricia Tanzi,Nicole Gonzales,Chad Tremont,Chitra Venkatasubramanian,Rosita Thiessen,Supriya Save,Steven Verrault,Karin Collard,Michael DeGeorgia,Valerie Cwiklinski,Bradford Thompson,Lesley Wasilewski,Charles Andrews,Robert Burfeind,Michel Torbey,Mohammad Hamed,Kenneth Butcher,Leka Sivakumar,Nicolaou Varelas,Kathleen Mays-Wilson,Enrique Leira,Heena Olalde,Scott Silliman,Rhonda Calhoun,Neha Dangayach,Ricardo Renvill,Rishi Malhotra,Kristina Kordesch,Aaron Lord,Thomas Calahan,Romergryko Geocadin,Michelle Parish,James Frey,Mary Harrigan,Dana Leifer,Ryna Mathias,Michael Schneck,Tara Bernier,Sergio Gonzales-Arias,Josette Elysée,George Lopez,Josephine Volgi,Robert Brown,Sara Jasak,Stephen Phillips,J Jarrett,João Gomes,Moneen McBride,François Aldrich,Charlene Aldrich,Joshua Kornbluth,Michelle Bettle,Joshua Goldstein,Gregory Tirrell,Qaisar Shaw,Karin Jonczak
+82 authors
,Kennedy LeesJournal
Published
Mar 18, 2019
Show more
Save
Tip0
TipSave